5u5f
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (Ac) CQFDA(PH)2STRRLRCGGSK== | |
| - | + | <StructureSection load='5u5f' size='340' side='right' caption='[[5u5f]], [[Resolution|resolution]] 1.81Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5u5f]] is a 5 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5U5F OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5U5F FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MRY:MESO-ERYTHRITOL'>MRY</scene></td></tr> | |
| - | [[Category: | + | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=2GX:BETA-PHENYL-L-PHENYLALANINE'>2GX</scene>, <scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene></td></tr> |
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5u3d|5u3d]], [[5u5m|5u5m]], [[5u6a|5u6a]]</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5u5f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5u5f OCA], [http://pdbe.org/5u5f PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5u5f RCSB], [http://www.ebi.ac.uk/pdbsum/5u5f PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5u5f ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Avery, K N]] | ||
| + | [[Category: Bzymek, K P]] | ||
| + | [[Category: Williams, J C]] | ||
[[Category: Zer, C]] | [[Category: Zer, C]] | ||
| - | [[Category: | + | [[Category: Immune system]] |
| - | + | ||
| - | + | ||
Revision as of 06:22, 14 March 2018
MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (Ac) CQFDA(PH)2STRRLRCGGSK
| |||||||||||
